Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares RepurchasedShort-Term Debt repayments
Ratios

Viemed Healthcare (VMD) Cost of Revenue (2018 - 2025)

Viemed Healthcare (VMD) has disclosed Cost of Revenue for 6 consecutive years, with $32.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cost of Revenue rose 30.63% year-over-year to $32.1 million, compared with a TTM value of $114.8 million through Dec 2025, up 26.1%, and an annual FY2025 reading of $114.8 million, up 26.1% over the prior year.
  • Cost of Revenue was $32.1 million for Q4 2025 at Viemed Healthcare, up from $30.6 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $32.1 million in Q4 2025 and bottomed at $9.8 million in Q2 2021.
  • Average Cost of Revenue over 5 years is $18.7 million, with a median of $17.9 million recorded in 2023.
  • The sharpest move saw Cost of Revenue tumbled 42.26% in 2021, then skyrocketed 33.69% in 2024.
  • Year by year, Cost of Revenue stood at $12.3 million in 2021, then rose by 18.8% to $14.6 million in 2022, then grew by 27.48% to $18.6 million in 2023, then soared by 31.83% to $24.6 million in 2024, then skyrocketed by 30.63% to $32.1 million in 2025.
  • Business Quant data shows Cost of Revenue for VMD at $32.1 million in Q4 2025, $30.6 million in Q3 2025, and $26.3 million in Q2 2025.